معرفی
Dr. Suchitra Krishnan-Sarin is the Albert E. Kent Professor of Psychiatry at Yale University School of Medicine and serves as Chair of the Human Investigations Committee (IRB) within Yale's Human Research Protections Program. She also holds a secondary appointment as Professor in Chronic Disease Epidemiology. Her extensive institutional affiliations include the Cancer Prevention and Control Center, Center for Nicotine and Tobacco Use Research at Yale (CENTURY), Center for the Translational Neuroscience of Alcohol, Connecticut Mental Health Center, Division of Addictions, Division of Women's Behavioral Health Research, Neuroscience Research Training Program, Psychiatry Psychology Section, Psychotherapy Development Center, Substance Abuse Research, Yale Cancer Center, Yale School of Public Health, Yale Tobacco Center of Regulatory Science, and Yale Ventures.
Dr. Krishnan-Sarin earned her PhD from Purdue University in 1992, completed a postdoctoral fellowship at Indiana University Purdue University at Indianapolis in 1995, and a postdoctoral fellowship at Yale University in 1996. Her educational background laid the foundation for her pioneering work in substance use research.
Dr. Krishnan-Sarin's research program focuses on developing a bio-behavioral understanding of substance use behaviors in adult and adolescent populations, with the goal of creating optimal prevention and cessation interventions. Her work spans multiple domains including adolescent tobacco use, e-cigarette research, alcohol use disorders, and tobacco regulatory science. She employs a multidisciplinary approach that integrates behavioral, neuroimaging, and pharmacological methods to understand the appeal, abuse potential, and patterns of substance use. Her adolescent tobacco research examines the impact of flavors and other constituents in tobacco products on addiction, while her adult research develops pharmacological interventions for alcohol use disorders.
She has made significant contributions to national and international tobacco regulatory efforts, serving on the FDA's Tobacco Product Scientific Advisory Committee and the CDC's Interagency Commission on Smoking and Health. Her work has directly informed the Surgeon General's reports on youth tobacco use behaviors and has shaped evidence-based tobacco control policies.
Analysis of Dr. Krishnan-Sarin's recent publications reveals a strong emphasis on understanding the appeal of flavored tobacco products, particularly among youth and young adults. Her research consistently examines how flavor additives influence product appeal, sensory experience, and behavioral intentions. There is a clear progression from basic science investigations of nicotine delivery mechanisms to applied research on cessation interventions and policy implications. Her work increasingly addresses health disparities, with attention to vulnerable populations including LGBTQ youth and examining how targeted marketing influences tobacco use behaviors.
- Young Investigator Award (1997) from Society for Research on Nicotine and Tobacco
- President of Society for Research on Nicotine and Tobacco (2020-present)
- Contributor to Surgeon General's Report "Preventing Tobacco Use Among Young People"
- Contributor to Institute of Medicine of the National Academies Report "Scientific Standards for Studies on Modified Risk Tobacco Products"
Dr. Krishnan-Sarin has secured substantial funding for her research, including serving as Co-PI on the Yale Tobacco Centers Of Regulatory Science funded by NIH and FDA, which uses a multidisciplinary approach to understand tobacco and nicotine addiction. She also leads the ENACT initiative funded by the American Heart Association focused on developing e-cigarette cessation interventions for youth. Her clinical trial portfolio includes studies on varenicline for e-cigarette dependence, cannabis exposure effects on neurodevelopment, and imaging smoking-induced dopamine release. Her frequent collaborators include Grace Kong, Meghan Morean, Krysten Bold, Dana Cavallo, and Danielle Davis, indicating a strong network of researchers working across multiple institutions.
Dr. Krishnan-Sarin leads several major research initiatives including the Yale Tobacco Center of Regulatory Science (CENTURY), which examines how flavors and other constituents of tobacco products influence addiction. Her ENACT initiative develops behavioral interventions for e-cigarette use among youth. Through her role as IRB Chair, she oversees human subjects research at Yale, ensuring ethical standards while facilitating innovative research. Her work bridges laboratory science, clinical intervention development, and population-level policy impact, creating a comprehensive approach to addressing substance use disorders.